Clinical Trials in South Portland, United States
Locations / South Portland, United States
Delta Trials hosts 38 clinical trials conducted in South Portland, United States, making it a notable site of clinical research activity. These trials covering 195 medical conditions and multiple therapeutic areas, reflecting the scope and diversity of clinical research in this location. The trial counts on this page reflect the most recent data ingested from ClinicalTrials.gov, tracking research history across multiple versions for South Portland.
38
Total Trials
195
Conditions
0
Terminated since 2020
Browse by condition (195 total)
- Acute myeloid leukemia 6 trialsAll Acute myeloid leukemia trials
- Stage iiib lung cancer ajcc v8 5 trialsAll Stage iiib lung cancer ajcc v8 trials
- Lung non-small cell carcinoma 4 trialsAll Lung non-small cell carcinoma trials
- Stage iiia lung cancer ajcc v8 4 trialsAll Stage iiia lung cancer ajcc v8 trials
- Stage ii lung cancer ajcc v8 3 trialsAll Stage ii lung cancer ajcc v8 trials
- All Stage ii lung non-small cell cancer ajcc v7 trials
- Stage iii lung cancer ajcc v8 3 trialsAll Stage iii lung cancer ajcc v8 trials
- All Stage ib lung non-small cell carcinoma ajcc v7 trials
- Stage iv lung cancer ajcc v8 3 trialsAll Stage iv lung cancer ajcc v8 trials
- All Stage iiia lung non-small cell cancer ajcc v7 trials
- Malignant solid neoplasm 3 trialsAll Malignant solid neoplasm trials
- Advanced malignant solid neoplasm 2 trialsAll Advanced malignant solid neoplasm trials
- Ovarian carcinoma 2 trialsAll Ovarian carcinoma trials
- All Acute myeloid leukemia post cytotoxic therapy trials
- Stage iiic lung cancer ajcc v8 2 trialsAll Stage iiic lung cancer ajcc v8 trials
- Small lymphocytic lymphoma 2 trialsAll Small lymphocytic lymphoma trials
- Sarcomatoid renal cell carcinoma 2 trialsAll Sarcomatoid renal cell carcinoma trials
- All Acute myeloid leukemia, myelodysplasia-related trials
- Stage iv ovarian cancer ajcc v8 2 trialsAll Stage iv ovarian cancer ajcc v8 trials
- All Anatomic stage iii breast cancer ajcc v8 trials